Learn more

ZELDIS JEROME B

Overview
  • Total Patents
    46
About

ZELDIS JEROME B has a total of 46 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are HANA BIOSCIENCES INC, TSUJI AKIRA and ORGANEXT RES B V.

Patent filings in countries

World map showing ZELDIS JEROME Bs patent filings in countries
# Country Total Patents
#1 United States 46

Patent filings per year

Chart showing ZELDIS JEROME Bs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zeldis Jerome B 46
#2 Faleck Herbert 5
#3 Manning Donald C 5
#4 Schafer Peter H 5
#5 Khetani Vikram 3
#6 Zeitlin Andrew L 3
#7 Faleck Herbert J 3
#8 Rohane Patricia E 3
#9 Stirling David I 3
#10 Dariani Maghsoud M 3

Latest patents

Publication Filing date Title
US2013136770A1 Methods for treating respiratory viral infection
US2011172273A1 Methods of treating myelodysplastic syndromes using lenalidomide
US2014004182A1 Methods for the treatment of sarcoidosis
US2010278779A1 Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
US2010129363A1 Methods and compositions using pde4 inhibitors for the treatment and management of cancers
US2007155791A1 Methods for treating cutaneous lupus using aminoisoindoline compounds
US2006270707A1 Methods and compositions using 4-[(cyclopropanecarbonylamino)methyl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione for the treatment or prevention of cutaneous lupus
US2005222209A1 Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
US2007190070A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
US2008027113A1 Methods of Using and Compositions Comprising Immunomodulatory Compounds for Treatment and Management of Macular Degeneration
US2007161696A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain